Supplementary Data Table 5 from Adaptive Resistance to Dual BRAF/MEK Inhibition in BRAF-Driven Tumors through Autocrine FGFR Pathway Activation
Year: 2023
Type: supplementary-materials
Abstract: Table S5 shows the raw counts from RNA sequencing of paired non-small cell lung cancer samples with BRAF mutations pre- and post-treatment using BRAF/MEK inhibitor combinations
Authors: Victoria E. Wang, Jenny Y. Xue, Dennie T. Frederick, Yi Cao, Eva Lin, Catherine Wilson, Anatoly Urisman, David P. Carbone, Keith T. Flaherty, Rene Bernards, Piro Lito, Jeff Settleman, Frank McCormick
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361887518